129 related articles for article (PubMed ID: 35661106)
1. Development and characterization of gastro-floating sustained-release capsule with improved bioavailability of levodopa.
Yuan H; Zhang Z; Hu L
Drug Deliv Transl Res; 2023 Jan; 13(1):9-17. PubMed ID: 35661106
[TBL] [Abstract][Full Text] [Related]
2. Development, Optimization, and Evaluation In Vitro/In Vivo of Oral Liquid System for Synchronized Sustained Release of Levodopa/Benserazide.
Qu Y; Lai WL; Xin YR; Zhu FQ; Zhu Y; Wang L; Ding YP; Xu Y; Liu HF
AAPS PharmSciTech; 2019 Sep; 20(8):312. PubMed ID: 31529266
[TBL] [Abstract][Full Text] [Related]
3. Improved Bioavailability of Levodopa Using Floatable Spray-Coated Microcapsules for the Management of Parkinson's Disease.
Baek JS; Tee JK; Pang YY; Tan EY; Lim KL; Ho HK; Loo SCJ
Neuromolecular Med; 2018 Jun; 20(2):262-270. PubMed ID: 29696585
[TBL] [Abstract][Full Text] [Related]
4. Preparation and pharmacokinetics study on gastro-floating sustained-release tablets of troxipide.
Gao Y; Gao Y; Yin F; Wang M; Wang Z; Ye T; Yang Y; Pan WS; Yang X
Drug Dev Ind Pharm; 2015; 41(9):1443-51. PubMed ID: 25190152
[TBL] [Abstract][Full Text] [Related]
5. Design and optimization of gastro-floating sustained-release tablet of pregabalin: In vitro and in vivo evaluation.
Qin C; Wu M; Xu S; Wang X; Shi W; Dong Y; Yang L; He W; Han X; Yin L
Int J Pharm; 2018 Jul; 545(1-2):37-44. PubMed ID: 29649518
[TBL] [Abstract][Full Text] [Related]
6. Development and Evaluation of Compression Coating Gastro-Floating Tablet of Alfuzosin Hydrochloride for Zero-Order Controlled Release.
Gong L; Sun Y; Yu M; Gao Y; Zou M; Cheng G
AAPS PharmSciTech; 2018 Oct; 19(7):3277-3286. PubMed ID: 30215168
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)).
Hsu A; Yao HM; Gupta S; Modi NB
J Clin Pharmacol; 2015 Sep; 55(9):995-1003. PubMed ID: 25855267
[TBL] [Abstract][Full Text] [Related]
8. Design and in vitro/in vivo evaluation of sustained-release floating tablets of itopride hydrochloride.
Ahmed SM; Ahmed Ali A; Ali AM; Hassan OA
Drug Des Devel Ther; 2016; 10():4061-4071. PubMed ID: 28008229
[TBL] [Abstract][Full Text] [Related]
9. Gastro-floating tablets of cephalexin: preparation and in vitro/in vivo evaluation.
Yin L; Qin C; Chen K; Zhu C; Cao H; Zhou J; He W; Zhang Q
Int J Pharm; 2013 Aug; 452(1-2):241-8. PubMed ID: 23680730
[TBL] [Abstract][Full Text] [Related]
10. Fabrication of gastro-floating sustained-release etoricoxib and famotidine tablets: design, optimization
Saady M; Shoman NA; Teaima M; Abdelmonem R; El-Nabarawi MA; Elhabal SF
Pharm Dev Technol; 2024 Jun; 29(5):429-444. PubMed ID: 38607310
[TBL] [Abstract][Full Text] [Related]
11. Comparative single- and multiple-dose pharmacokinetics of levodopa and 3-O-methyldopa following a new dual-release and a conventional slow-release formulation of levodopa and benserazide in healthy subjects.
Gasser UE; Crevoisier C; Ouwerkerk M; Lankhaar G; Dingemanse J
Eur J Pharm Biopharm; 1998 Sep; 46(2):223-8. PubMed ID: 9795070
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of L-dopa after Madopar HBS administration in healthy volunteers.
Crevoisier C; Hoevels B; Zürcher G; Da Prada M
Eur Neurol; 1987; 27 Suppl 1():36-46. PubMed ID: 3428308
[TBL] [Abstract][Full Text] [Related]
13. Tablets compressed with gastric floating pellets coated with acrylic resin for gastro retention and sustained release of famotidine: in-vitro and in-vivo study.
Qi X; Jiang Y; Zhang H; Wu Z
J Pharm Pharmacol; 2015 Apr; 67(4):493-500. PubMed ID: 25495700
[TBL] [Abstract][Full Text] [Related]
14. [The pharmacokinetics and bioequivalence of acipimox sustained-release tablets after a single and multiple oral administration in healthy dogs].
Yang XG; Nie SF; Bai HJ; Zhang GJ; Pan WS
Yao Xue Xue Bao; 2005 May; 40(5):457-61. PubMed ID: 16220793
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of gastro-swelling/gastro-floating sustained-release tablets of brivaracetam for epilepsy therapy.
Hou Z; Cheng X; Zhao X; Lin J; Zhang H; Li Y; Ding J
Int J Pharm; 2023 Sep; 644():123301. PubMed ID: 37572859
[TBL] [Abstract][Full Text] [Related]
16. Preparation and
Liu H; Xie X; Chen C; Firempong CK; Feng Y; Zhao L; Yin X
Drug Dev Ind Pharm; 2021 Mar; 47(3):394-402. PubMed ID: 33615926
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and characterization of osmotic pump capsules containing polyoxyethylene and pH modifier to control the release of nifedipine.
Yu J; Meng X; Dong X; Han M; Li G; Chen Y; Liu Y; Hu L
Eur J Pharm Biopharm; 2021 Jun; 163():102-108. PubMed ID: 33819628
[TBL] [Abstract][Full Text] [Related]
18. New levodopa sustained-release floating minitablets coated with insoluble acrylic polymer.
Goole J; Deleuze P; Vanderbist F; Amighi K
Eur J Pharm Biopharm; 2008 Feb; 68(2):310-8. PubMed ID: 17804212
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic characteristics of a new multiple unit sustained release formulation of sodium valproate.
Wangemann M; Retzow A; Vens-Cappell B
Int J Clin Pharmacol Ther; 1999 Feb; 37(2):100-8. PubMed ID: 10082174
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
